Document Type

Article

Publication Date

9-1-2010

Comments

This article is peer reviewed. It is published in Oncology Reports, 2010 Sep;24(3):767-9. ©Spandidos Publications

Abstract

While hepatic arterial chemoembolization is efficacious for a number of malignancies, there is scant data regarding treatment of pancreatic adenocarcinoma. We report a complete radiographic response at one year from diagnosis of metastatic pancreatic carcinoma. Gemcitabine/cisplatin based chemoembolization may be of potential benefit for patients with liver-dominant metastases from pancreatic carcinoma. Given the typical survival of 6 months or less in this patient group with standard therapies, further research is warranted.

Share

COinS